Global Soft Tissue Repair Market – Industry Trends and Forecast to 2030

Soft Tissue Repair Market Analysis and Size

Product innovation is increasing in the healthcare industry. An additional result of market research and development activities is the development of novel, cutting-edge devices. Surgery is currently the most common form of treatment but has a low success rate. So it's crucial to use superior, modern alternatives like minimally invasive methods and products that hasten to heal. Currently, most treatments available involve risky surgical procedures. Using widely adopted, cutting-edge options like minimally invasive techniques and fast-healing products is crucial.

Data Bridge Market Research analyses that the soft tissue repair market, valued at USD 22,211.53 million in 2022, will reach USD 35,082.45 million by 2030, growing at a CAGR of 5.88% during the forecast period of 2023 to 2030.  In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Soft Tissue Repair Market Scope and Segmentation  

Market Definition

Soft tissue healing is the body's natural process of replacing destroyed tissue with living tissue. Both regeneration and repair are steps in this process. Pain and swelling are brought on by soft tissue injuries, which are caused by damage to the tendons, ligaments, and muscles. In soft tissue repairs, healthy tissues are substituted for harmed or damaged ones. Any soft tissue damage, such as a torn muscle, twisted knee, or sprained ankle, triggers the body's tissue healing process.

Soft Tissue Repair Market Dynamics

Drivers

• Rising obesity rates and population growth drives the market

Aging populations and rising obesity rates are expected to fuel market growth throughout the forecast period. When tissues become weak due to aging and obesity, accidents can cause severe injuries.  One statistic is that more than 1 billion people worldwide are obese, according to the World Health Organization (WHO). This amount is still increasing. The World Health Organization (WHO) projects that by 2025, 167 million children and adults will be in poorer health due to their weight, which increases the need for soft tissue repair. Thus, it contributes to market expansion.

• Chronic conditions lead to market growth

Physiological changes brought on by aging and metabolic inefficiencies are frequently the root cause of chronic diseases such as cystic fibrosis, hepatitis, cardiovascular disease, and cancer. Globally, 900 million people will be 65 or older in 2020.  For instance, according to WHO data from July 2022, 1.71 billion people worldwide have musculoskeletal disorders. With 441 million people worldwide, high-income countries are the most affected, leading to the market's growth.

Opportunities

• An increase in fractures caused by osteoporosis drives the market

Advanced sports injuries such as ankle sprains, hip muscle strains, tendonitis, bursitis, and stress fractures are on the rise among young people because of their growing interest in sports. Thus, recovery systems are also needed further creates a demand for the soft tissues repair. For instance, a report released in June 2022 by Orthopedic Specialists of Oakland County (OSOC), a provider of orthopedic services, found that 21% of all traumatic brain injuries among children in the U.S. occur as a result of participation in sports and leisure activities, thus growing sports activities has created opportunities to grow.

• Advancements in technology have created expansion

The soft tissue repair industry continues to innovate and advance technologically. The management of complex musculoskeletal and neuromuscular pain brought on by an orthopedic ligament tear can be successfully accomplished with the help of therapies like platelet-rich plasma and others. In order to improve the efficacy of these procedures, new developments, such as cutting-edge surgical methods, are also emerging in soft tissue reconstruction. The need for minimally invasive procedures is becoming more and more important. Compared to invasive procedures, these procedures cause less trauma and have faster recovery times. Which further creates lucrative opportunities to grow.

Restraints/Challenges

• High costs and unfavorable reimbursement could prevent further growth

High costs and unfavorable reimbursement policies hamper the growth of the soft tissue repair industry. For instance, the cost of an anterior cruciate ligament (ALC) soft tissue repair for those without health insurance ranges from USD 20,000 to USD 50,000. It includes the cost of the surgery, facilities, anaesthesia, and the graft. Most patients in low- and middle-income countries cannot afford the procedures. Additionally, many people find it difficult to pay for the treatment.

• Lack of knowledge prevents growth

The low level of public awareness of the benefits of soft tissue repair also restrains the market's expansion rate. Medical professionals also accept biological products less readily due to a lack of awareness, which hinders growth. Medical professionals and surgeons may use soft tissue repair products incorrectly or ineffectively due to a lack of appropriate knowledge. This may lead to accidents or even legal action against the business or disgruntled customers, which could have a negative impact on the tissue repair market.

• A lack of investment in research and development constrains growth

Further slowing the market growth rate is a nation's lack of investment in research and development. The development of regenerative therapies is further hampered by the absence of uniform standards across regions, particularly for biomedical and tissue engineering research. This directly increases the burden of regulations for product manufacturers, particularly in low- and middle-income countries.

This soft tissue repair market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the soft tissue repair market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Citrefix, a suture anchor system for surgical procedures on the foot and ankle, was introduced by Stryker. Citrefix is a resorbable, bio-inspired suture anchor system for single-use sutures. Citregen, an elastomeric substance made from a citrate polymer and specifically created to mimic bone chemistry for controlled resorption without persistent inflammation, is used in its construction. When used in orthopedic surgical applications, these special chemical and mechanical properties are intended to aid in healing grafted tissue and encourage sound bone growth.
• In 2022, The Grappler Suture Anchor System was introduced by Paragon 28, Inc. to address the difficulties in performing ligament reconstruction and soft tissue tensioning during acute foot and ankle procedures. Paragon 28 designed its acute Grappler PEEK and titanium anchors for effectiveness in the operating room. The PEEK anchors are available in a single kit that contains all the tools required to finish the repair. The sutures and needles are inside the anchors, which come in sizes 4.5 and 5.5.
• In 2022, the U.S.-based start-up Avita Medical published the final results of research it had conducted in patients with soft tissue injuries using its recently released RECELL System. According to the trial's findings, the RECELL System has successfully treated some of the deadliest flesh-eating diseases, surgical wounds, and severe skin injuries.
• In 2021, Tissuemed, Ltd. (U.K.) was acquired by BD; this acquisition enhances BD's core portfolio by bringing a surgical sealant with a wide range of applications to a line of BD biosurgery products already used in the operating room.

Global Soft Tissue Repair Market Scope

The soft tissue repair market is segmented on the basis of product, application, injury locations and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Tissue Patch/Mesh
• Synthetic Mesh
• Biological Mesh
• Allograft
• Xenograft
• Alloplast
• Fixation Devices
• Suture Anchors
• Sutures
• Interference Screws
• Others
• Laparoscopic Instruments

Application

• Hernia Repair
• Skin Repair
• Dermatalogy
• Pelvic and Vaginal Sling Procedures
• Orthopedic Repair
• Sports Medicine
• Dural Repair
• Others
• Dental Repair
• Breast Reconstruction Repair
• Head and neck Products
• Others

Injury Location

• Knee
• Shoulder
• Hip
• Small Joints

End Use

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

Soft Tissue Repair Market Regional Analysis/Insights

The soft tissue repair market is analysed and market size insights and trends are provided by country, product, application, injury locations and end use as referenced above.

The countries covered in the soft tissue repair market report are  U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are growth of the soft tissue repair market in the region will also be aided during the forecast period by the rise in the elderly population and the number of trauma cases.

Asia-Pacific will undergo the highest growth rate during the forecast period owing to the rise in surgical procedures for soft tissue repair, which will further fuel the expansion of the soft tissue repair market in the region over the ensuing years. Additionally, there is a rise in healthcare costs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Soft Tissue Repair Market Share Analysis

The soft tissue repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to soft tissue repair market.

Some of the major players operating in the soft tissue repair market are:

• Johnson & Johnson Private Limited (India)
• Smith & Nephew plc (U.K.)
• Integra LifeSciences (U.S.)
• BD (U.S.)
• LifeCell International Pvt. Ltd. (India)
• Organogenesis Inc. (U.S.)
• Medtronic (Ireland)
• Stryker (U.S.)
• Arthrex, Inc. (U.S.)
• Wright Medical Group N.V. (U.S.)
• Boston Scientific Corporation (U.S.)
• AbbVie Inc. (Ireland)
• CryoLife, Inc. (U.S.)
• Athersys, Inc. (U.S.)
• Zimmer Biomet (U.S.)
• LifeNet Health, (U.S.)
• Stem Cell, Inc. (U.S.)
• Isto Biologics (U.S.)

SKU-12257